Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
Shanmeng Lin, Shih‐Chao Lin, Jia-Ning Hsu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 6, pp. 3131-3141
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Sisi Kang, Mei Yang, Zhongsi Hong, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 7, pp. 1228-1238
Open Access | Times Cited: 656
COVID-19: Drug Targets and Potential Treatments
Carmen Gil, Tiziana Ginex, Inés Maestro, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12359-12386
Open Access | Times Cited: 433
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 347
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Bo Han, Xiang‐Hong He, Yanqing Liu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 3, pp. 1522-1586
Closed Access | Times Cited: 314
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Arun K. Ghosh, Margherita Brindisi, Dana Shahabi, et al.
ChemMedChem (2020) Vol. 15, Iss. 11, pp. 907-932
Open Access | Times Cited: 292
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation
Zhihua Bai, Ying Cao, Wenjun Liu, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1115-1115
Open Access | Times Cited: 282
Structures of the SARS ‐CoV‐2 nucleocapsid and their perspectives for drug design
Ya Peng, Ning Du, Yuqing Lei, et al.
The EMBO Journal (2020) Vol. 39, Iss. 20
Open Access | Times Cited: 256
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Kawthar Mohamed, Niloufar Yazdanpanah, Amene Saghazadeh, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104490-104490
Open Access | Times Cited: 148
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 139
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
Nicholas A. Wong, Milton H. Saier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1308-1308
Open Access | Times Cited: 119
Molecular Glue Discovery: Current and Future Approaches
Jeffrey A. Dewey, Clémence Delalande, Saara‐Anne Azizi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9278-9296
Open Access | Times Cited: 44
Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 21
Smoking and COVID-19: Adding Fuel to the Flame
Vivek K. Kashyap, Anupam Dhasmana, Andrew E. Massey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6581-6581
Open Access | Times Cited: 101
Fight against novel coronavirus: A perspective of medicinal chemists
Sk. Abdul Amin, Tarun Jha
European Journal of Medicinal Chemistry (2020) Vol. 201, pp. 112559-112559
Open Access | Times Cited: 73
Properties and Reactivities of Niclosamide in Different Media, a Potential Antiviral to Treatment of COVID-19 by Using DFT Calculations and Molecular Docking
Davide Romani, Olfa Noureddine, Noureddine Issaoui, et al.
Biointerface Research in Applied Chemistry (2020) Vol. 10, Iss. 6, pp. 7295-7328
Open Access | Times Cited: 71
Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication
Ting Cai, Zhenbao Yu, Zhen Wang, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100821-100821
Open Access | Times Cited: 64
Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
Karthik Vivekanandhan, Shanmugam Poornima, Hamed Barabadi, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 55
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity
Minghui Yang, Chunhui Li, Guoguo Ye, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
Ehsaneh Khodadadi, Parham Maroufi, Ehsan Khodadadi, et al.
Microbial Pathogenesis (2020) Vol. 146, pp. 104241-104241
Open Access | Times Cited: 67
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Sisi Kang, Mei Yang, Zhongsi Hong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53
Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function
Sadaqat Ali, Usman Ali, Adeem Qamar, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 16
Recent developments in molecular modeling tools and applications related to pharmaceutical and biomedical research
Paola Peluso, Bezhan Chankvetadze
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 238, pp. 115836-115836
Open Access | Times Cited: 16
Targeting protein-protein interaction interfaces with antiviral N protein inhibitor in SARS-CoV-2
Jhen-Yi Hong, Shih‐Chao Lin, Kylene Kehn‐Hall, et al.
Biophysical Journal (2024) Vol. 123, Iss. 4, pp. 478-488
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top